Investment
Features
FeesSafety
Academy
More
Pluang+

Nvidia's AI growth outpaces Eli Lilly's drug sales for next decade potential

Market News
21 Sep 2026
24/7 Wall Street
View Source
Bullish
Nvidia's AI growth outpaces Eli Lilly's drug sales for next decade potential

Nvidia and Eli Lilly both exceeded earnings expectations, but Nvidia's AI-driven data center growth offers a stronger long-term investment opportunity. Nvidia posted $96.22 billion in revenue, driven by AI infrastructure demand and supply constraints, with forecasts of 70% growth next fiscal year. Eli Lilly reported $22.97 billion, boosted by GLP-1 drugs like Mounjaro, but faces risks from drug price declines and product concentration. Nvidia's platform expansion and high margins position it better for the next decade, while Lilly suits more defensive investors seeking dividends and lower volatility.

Nvidia's market cap stands at $5.37 trillion as of Sep 21, 2026, highlighting its dominant position in the tech sector, compared to Eli Lilly's $1.03 trillion in health care. On Pluang, Nvidia shares trade at USD 224.56 with a 1.03% gain over the day, while Eli Lilly is priced at USD 1,166.87, up 1.27% as of the same time. Nvidia's typical hold time on Pluang is longer at 114 days, reflecting possibly greater investor confidence in its growth potential as of Sep 21, 2026 21:44 WIB.

More News (NVDA)

AMD shares jump 5% on report of 10% chip price hike amid rising wafer costs.

AMD shares jump 5% on report of 10% chip price hike amid rising wafer costs.

AMD shares rose 5% following a supply-chain report that the company plans a 10% price increase on AI accelerator chips, consumer graphics processors, and motherboard chipsets starting in Q4. The increase is linked to higher wafer costs from its found...

Market News
Bullish
5 hours ago
Dividend Harvesting Portfolio trimmed 20 stocks, adding NVDA and boosting income with 7.93% yield

Dividend Harvesting Portfolio trimmed 20 stocks, adding NVDA and boosting income with 7.93% yield

The Dividend Harvesting Portfolio underwent a major restructuring, exiting 20 positions to focus on higher-conviction stocks like NVDA, ORCL, SPYI, and GPIQ. Despite reducing the number of holdings, the portfolio retained nearly 90% of its forward an...

Others
Bullish
6 hours ago
Investor keeps buying Nvidia despite China risks and tech selloff due to strong AI demand and supply constraints.

Investor keeps buying Nvidia despite China risks and tech selloff due to strong AI demand and supply constraints.

An investor continues to buy Nvidia shares despite concerns over China and a tech sector selloff because Nvidia's AI-related products remain in high demand and supply-constrained. Nvidia reported 105.85% year-over-year revenue growth, with management...

Market News
Bullish
6 hours ago
Semiconductor stocks show strong fundamentals despite market skepticism, driven by AI chip demand and rising earnings forecasts.

Semiconductor stocks show strong fundamentals despite market skepticism, driven by AI chip demand and rising earnings forecasts.

Despite market skepticism, semiconductor stocks, especially Nvidia and Broadcom, remain strong due to robust fundamentals and growing AI chip demand. Valuations are at multi-year lows even as industry earnings forecasts improve and compute capacity i...

Market News
Bullish
1 day ago
Investing $500 monthly in VOO since 2010 could grow to $330,000, highlighting the power of S&P 500 cap-weighted ETFs.

Investing $500 monthly in VOO since 2010 could grow to $330,000, highlighting the power of S&P 500 cap-weighted ETFs.

A $500 monthly investment in the Vanguard S&P 500 ETF (VOO) since its 2010 launch would be worth about $330,000 today, driven by mega-cap tech giants like Nvidia, Apple, and Microsoft. The article compares VOO with other S&P 500 ETFs like IVV, SPY, S...

Market News
Bullish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App